Morrisville.

PositionTriangle

MORRISVILLE -- Salix Pharmaceuticals failed to win federal approval for its balsalazide tablet, a stronger version of its ulcerative colitis treatment Colazal. The U.S. Food and Drug Administration requested...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT